Article Text
Abstract
Natural experiments are an important methodology often used to answer research questions that would, otherwise, be impossible to address, or employed because of ethical concerns about the use of randomisation to interventions that carry known risks. The UK Medical Research Council (MRC) recently produced an extremely useful document discussing the nature and significance of natural experiments within medical and public health research. In this paper, however, we suggest that the MRC document's definition of the term ‘natural experiment’ is insufficiently precise. In response, we offer a taxonomy of different types of natural experiments and related methods, and explore the ethical implications of these different types. We argue that while the ethical issues that may arise within natural experiments in relation to risks of harm or informed consent may differ from those within the randomised controlled trial, they are not thereby less pressing. The implications of the argument are explored and recommendations made for those involved in research governance.
- Research Ethics
- Informed Consent
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Health incentive research and social justice: does the risk of long term harms to systematically disadvantaged groups bear consideration?
- Forever young? The ethics of ongoing puberty suppression for non-binary adults
- Challenge studies of human volunteers: ethical issues
- Public health use of HIV phylogenetic data in sub-Saharan Africa: ethical issues
- Informed consent in cluster randomised trials: new and common ethical challenges
- Using natural experiments to evaluate population health interventions: new Medical Research Council guidance
- Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?
- ‘Dark logic’: theorising the harmful consequences of public health interventions
- Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent